Clinical Trials Directory

Trials / Completed

CompletedNCT01181219

Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of Keratoconus

Behandling av Keratoconus Med "Cornea Collagen Cross-linking" Uten Hornhinneepitelfjerning

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University Hospital of North Norway · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Transepithelial CXL (performed without epithelial removal) seem to have similar clinical effect on keratoconic eyes compared to the standard CXL (which includes epithelial removal). The current study attempts to prove that hypothesis. A prospective, controlled, randomized, contralateral trial, will involve one eye of the patient to be treated with transepithelial CXL, while the control eye will be treated with the standard CXL. Totally 20 patients (age \>18 and \<40 years) referred by an ophthalmologist to the eye department of the University Hospital North Norway for CXL treatment of bilateral progressive keratoconus, will be recruited.

Detailed description

CXL appears to hinder the development of keratoconus by strengthening the cross-bindings in the corneal stroma with a resultant increase in corneal biomechanical strength of up to 300%. The method was introduced in the mid-nineties and has been approved for use in the EU countries since 2007. Standard treatment protocol, involving the removal of the corneal epithelium before the Riboflavin application, has been used. In order to avoid potential complications following removal of the epithelium (infection, delayed healing, scar formation, as well as discomfort and pain), a modified procedure where the epithelium is kept intact, so called transepithelial CXL, has been suggested. According to the preliminary results of the published retrospective studies, no significant difference in the clinical effect between the standard CXL with epithelial removal and the transepithelial CXL was found.

Conditions

Interventions

TypeNameDescription
PROCEDURECXL without epithelial removalUV-radiation of a Riboflavin saturated cornea without prior epithelial removal
PROCEDURECXL with epithelial removalUV-radiation of a Riboflavin saturated cornea after surgical epithelial removal has been performed

Timeline

Start date
2010-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2010-08-13
Last updated
2014-12-12

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01181219. Inclusion in this directory is not an endorsement.